bioAffinity Technologies, Inc.

Stock Chart, Company Information, and Scan Results

$4.73(as of Mar 23, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

bioAffinity Technologies, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$4.73
Ticker SymbolBIAF
ExchangeNasdaq
SectorHealthcare
IndustryDiagnostics & Research
Employees57
CountyUSA
Market Cap$12.3M

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

bioAffinity Technologies, Inc. In Our Stock Scanner

As of Mar 24, 2026
As of ---
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.